Literature DB >> 22931453

Surgical outcomes of hepatocellular carcinoma originating from caudate lobe.

Yanming Zhou1, Xiaofeng Zhang, Lupeng Wu, Donghui Xu, Bin Li.   

Abstract

BACKGROUND: Caudate resection for hepatocellular carcinoma (HCC) remains a challenging procedure. This study aimed to assess the surgical outcomes of HCC originating from caudate lobe.
METHODS: Twenty-three patients with HCC in the caudate lobe who received surgical treatment were retrospectively reviewed.
RESULTS: Surgical procedures included 13 isolated caudatectomy (56.5%) and 10 combined caudatectomy (43.5%). Eight patients (34.7%) experienced post-operative complications. Mortality was nil. The 1-, 3- and 5-year overall survival rates after surgery were 90.1%, 60% and 37%, respectively. Isolated caudatectomy was associated with less frequent tumours located in paracaval portion, longer operative time, longer vascular occlusion time and more blood loss than combined caudatectomy (P < 0.05).
CONCLUSION: Surgical resection is feasible and beneficial for patients with HCC in the caudate lobe. If liver functional reserve is sufficient, combined caudatectomy is preferred.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 22931453     DOI: 10.1111/j.1445-2197.2012.06232.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  2 in total

1.  Prognoses and Clinicopathological Characteristics for Hepatocellular Carcinoma Originating from the Caudate Lobe After Surgery.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Akihisa Nagatsu; Takanori Ohata; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Surgical Strategy for Resecting Hepatocellular Carcinoma in the Caudate Lobe: Isolated or Combined Lobectomy? A Single-Center Study and Meta-Analysis.

Authors:  Zheng-Gang Xu; Fei-Hong Zhang; Dong-Wei Sun; Qi-Tong Zheng; Gu-Wei Ji; Ke Wang
Journal:  J Hepatocell Carcinoma       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.